SEC Form 4 · accession 0001144204-16-111678
REPROS THERAPEUTICS INC. · RPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jaye Thompson
Officer — See Remarks
Period of report
Jul 5, 2016
Accepted (ET)
Jul 6, 2016 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000897075
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2,F1 | $1.73 | Jul 5, 2016 | A | 10,000 | A | — | Jul 5, 2026 | Common | 10,000 | 10,000 | D |
Explanation of responses
- F1Option shares shall vest in equal annual installments on the first three year anniversaries of the date of grant.
- F2Received as employment compensation.
Remarks
Senior V.P. of Clinical and Regulatory Affairs